Allianz Asset Management GmbH trimmed its holdings in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 4.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,783,638 shares of the real estate investment trust's stock after selling 350,991 shares during the period. Allianz Asset Management GmbH owned about 1.13% of Medical Properties Trust worth $29,237,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also made changes to their positions in MPW. Novem Group lifted its position in shares of Medical Properties Trust by 8.1% in the first quarter. Novem Group now owns 27,606 shares of the real estate investment trust's stock worth $166,000 after buying an additional 2,058 shares in the last quarter. Beacon Financial Advisory LLC lifted its position in shares of Medical Properties Trust by 13.4% in the first quarter. Beacon Financial Advisory LLC now owns 20,196 shares of the real estate investment trust's stock worth $122,000 after buying an additional 2,386 shares in the last quarter. HB Wealth Management LLC lifted its position in shares of Medical Properties Trust by 7.1% in the first quarter. HB Wealth Management LLC now owns 38,657 shares of the real estate investment trust's stock worth $233,000 after buying an additional 2,575 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Medical Properties Trust by 49.5% in the first quarter. Farther Finance Advisors LLC now owns 7,875 shares of the real estate investment trust's stock worth $47,000 after buying an additional 2,606 shares in the last quarter. Finally, Focus Partners Wealth lifted its position in shares of Medical Properties Trust by 11.7% in the first quarter. Focus Partners Wealth now owns 32,690 shares of the real estate investment trust's stock worth $197,000 after buying an additional 3,415 shares in the last quarter. 71.79% of the stock is currently owned by hedge funds and other institutional investors.
Medical Properties Trust Price Performance
NYSE MPW opened at $5.15 on Friday. Medical Properties Trust, Inc. has a 52 week low of $3.51 and a 52 week high of $6.34. The company has a current ratio of 2.76, a quick ratio of 2.76 and a debt-to-equity ratio of 2.00. The stock has a market cap of $3.10 billion, a price-to-earnings ratio of -2.15 and a beta of 1.39. The company has a 50-day moving average price of $4.76 and a two-hundred day moving average price of $4.72.
Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The firm had revenue of $240.36 million during the quarter, compared to the consensus estimate of $231.90 million. During the same quarter last year, the company posted $0.23 EPS. Medical Properties Trust's revenue for the quarter was down 9.8% on a year-over-year basis. Analysts forecast that Medical Properties Trust, Inc. will post 0.78 EPS for the current year.
Medical Properties Trust Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, October 9th. Shareholders of record on Thursday, September 11th were given a $0.08 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.32 annualized dividend and a yield of 6.2%. Medical Properties Trust's dividend payout ratio is -13.39%.
Analyst Upgrades and Downgrades
A number of research firms recently commented on MPW. Weiss Ratings reiterated a "sell (d-)" rating on shares of Medical Properties Trust in a research report on Wednesday, October 8th. Royal Bank Of Canada decreased their target price on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research report on Monday, June 30th. Wall Street Zen cut Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. Zacks Research raised Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. Finally, Wells Fargo & Company reduced their price objective on Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating on the stock in a research note on Wednesday, August 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Reduce" and an average target price of $5.40.
Get Our Latest Report on Medical Properties Trust
About Medical Properties Trust
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.